Session

Therapeutic upper GI endoscopy

ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED HIGH-RISK MUCOSAL ADENOCARCINOMA AND LOW- AND HIGH-RISK SUBMUCOSAL ADENOCARCINOMA ARISING IN BARRETT'S ESOPHAGUS, RESULTS OF 120 PATIENTS FROM THE DUTCH BARRETT EXPERT CENTER COHORT
ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED HIGH-RISK MUCOSAL ADENOCARCINOMA AND LOW- AND HIGH-RISK SUBMUCOSAL ADENOCARCINOMA ARISING IN BARRETT'S ESOPHAGUS, RESULTS OF 120 PATIENTS FROM THE DUTCH BARRETT EXPERT CENTER COHORT

Therapeutic upper GI endoscopy  et al.

POOR HEALING AND POOR SQUAMOUS REGENERATION AFTER RADIOFREQUENCY ABLATION THERAPY FOR EARLY BARRETT'S NEOPLASIA: INCIDENCE, RISK FACTORS, AND OUTCOMES
POOR HEALING AND POOR SQUAMOUS REGENERATION AFTER RADIOFREQUENCY ABLATION THERAPY FOR EARLY BARRETT'S NEOPLASIA: INCIDENCE, RISK FACTORS, AND OUTCOMES

Therapeutic upper GI endoscopy  et al.

ADJUVANT EFFECT OF NEW HEMOSTATIC SPRAY 'NEXPOWDER' ON CONVENTIONAL ENDOSCOPIC TREATMENT IN MANAGING NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING: A PROSPECTIVE, MULTI-CENTER, RANDOMIZED CONTROLLED TRIAL
ADJUVANT EFFECT OF NEW HEMOSTATIC SPRAY 'NEXPOWDER' ON CONVENTIONAL ENDOSCOPIC TREATMENT IN MANAGING NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING: A PROSPECTIVE, MULTI-CENTER, RANDOMIZED CONTROLLED TRIAL

Therapeutic upper GI endoscopy  et al.

IS LOCAL ENDOSCOPIC RESECTION A VIABLE THERAPEUTIC OPTION FOR EARLY CLINICAL STAGE T1A AND T1B OESOPHAGEAL ADENOCARCINOMA? A PROPENSITY-MATCHED ANALYSIS
IS LOCAL ENDOSCOPIC RESECTION A VIABLE THERAPEUTIC OPTION FOR EARLY CLINICAL STAGE T1A AND T1B OESOPHAGEAL ADENOCARCINOMA? A PROPENSITY-MATCHED ANALYSIS

Therapeutic upper GI endoscopy  et al.

ENDOSCOPIC REASSESSMENT OF CT2N0M0 ESOPHAGEAL ADENOCARCINOMA LEADS TO DOWNSTAGING TO T1 TUMORS AND PREVENTS UNNECESSARY ADJUVANT TREATMENT: A MULTICENTER PROSPECTIVE COHORT STUDY
ENDOSCOPIC REASSESSMENT OF CT2N0M0 ESOPHAGEAL ADENOCARCINOMA LEADS TO DOWNSTAGING TO T1 TUMORS AND PREVENTS UNNECESSARY ADJUVANT TREATMENT: A MULTICENTER PROSPECTIVE COHORT STUDY

Therapeutic upper GI endoscopy  et al.

ADJUVANT EFFECT OF NEW HEMOSTATIC SPRAY 'NEXPOWDER' ON CONVENTIONAL ENDOSCOPIC TREATMENT IN MANAGING NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING: A PROSPECTIVE, MULTI-CENTER, RANDOMIZED CONTROLLED TRIAL
ADJUVANT EFFECT OF NEW HEMOSTATIC SPRAY 'NEXPOWDER' ON CONVENTIONAL ENDOSCOPIC TREATMENT IN MANAGING NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING: A PROSPECTIVE, MULTI-CENTER, RANDOMIZED CONTROLLED TRIAL

Therapeutic upper GI endoscopy

POOR HEALING AND POOR SQUAMOUS REGENERATION AFTER RADIOFREQUENCY ABLATION THERAPY FOR EARLY BARRETT'S NEOPLASIA: INCIDENCE, RISK FACTORS, AND OUTCOMES
POOR HEALING AND POOR SQUAMOUS REGENERATION AFTER RADIOFREQUENCY ABLATION THERAPY FOR EARLY BARRETT'S NEOPLASIA: INCIDENCE, RISK FACTORS, AND OUTCOMES

Therapeutic upper GI endoscopy

ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED HIGH-RISK MUCOSAL ADENOCARCINOMA AND LOW- AND HIGH-RISK SUBMUCOSAL ADENOCARCINOMA ARISING IN BARRETT'S ESOPHAGUS, RESULTS OF 120 PATIENTS FROM THE DUTCH BARRETT EXPERT CENTER COHORT
ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED HIGH-RISK MUCOSAL ADENOCARCINOMA AND LOW- AND HIGH-RISK SUBMUCOSAL ADENOCARCINOMA ARISING IN BARRETT'S ESOPHAGUS, RESULTS OF 120 PATIENTS FROM THE DUTCH BARRETT EXPERT CENTER COHORT

Therapeutic upper GI endoscopy

ENDOSCOPIC REASSESSMENT OF CT2N0M0 ESOPHAGEAL ADENOCARCINOMA LEADS TO DOWNSTAGING TO T1 TUMORS AND PREVENTS UNNECESSARY ADJUVANT TREATMENT: A MULTICENTER PROSPECTIVE COHORT STUDY
ENDOSCOPIC REASSESSMENT OF CT2N0M0 ESOPHAGEAL ADENOCARCINOMA LEADS TO DOWNSTAGING TO T1 TUMORS AND PREVENTS UNNECESSARY ADJUVANT TREATMENT: A MULTICENTER PROSPECTIVE COHORT STUDY

Therapeutic upper GI endoscopy

Item 1 - 9 / 9
1